Piechowiak, Rachel
Sajan, Abin
Isaacson, Ari
Lerner, Jade
Bagla, Sandeep
Funding for this research was provided by:
Terumo Medical
Article History
Received: 3 November 2022
Accepted: 23 March 2023
First Online: 11 April 2023
Declarations
:
: Ari Isaacson: Consulting fees (Boston Scientific, CrannMed); Payment (Terumo, Guerbet); Participation on a Data Safety Monitoring Board (Boston Scientific). Sandeep Bagla: Consulting fees (Medtronic, CrannMed, Boston Scientific, Terumo, Guerbet, Varian); Leadership (President & CEO Prostate Centers USA); Stock (MBiotechnologies, Embolx).
: Institutional IRB approval was provided by The Western Institutional Review Board—protocol number: 20181853) and received an Investigational Device Exemption (IDE NCT03676829) from the U.S. Food and Drug Administration.
: For this type of study, consent for publication is not required.
: Informed consent was obtained from all individual participants included in the study.